BioAge Labs, Inc.
BIOA
$10.18
$0.9610.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 24.25% | 157.54% | 346.29% | -- | -- |
| Gross Profit | -9.39% | -138.02% | -330.73% | -- | -- |
| SG&A Expenses | 62.96% | 64.89% | 54.44% | 32.00% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.97% | 84.61% | 67.53% | 61.56% | -- |
| Operating Income | -35.06% | -77.11% | -64.62% | -61.56% | -- |
| Income Before Tax | -6.84% | -27.14% | -8.03% | -11.36% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.84% | -27.14% | -8.03% | -11.36% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.84% | -27.14% | -8.03% | -11.36% | -- |
| EBIT | -35.06% | -77.11% | -64.62% | -61.56% | -- |
| EBITDA | -35.10% | -77.35% | -64.81% | -61.75% | -- |
| EPS Basic | 93.95% | 77.69% | 60.36% | 39.78% | -- |
| Normalized Basic EPS | 92.65% | 73.21% | 52.96% | 28.94% | -- |
| EPS Diluted | 93.95% | 77.69% | 60.36% | 39.78% | -- |
| Normalized Diluted EPS | 92.65% | 73.21% | 52.96% | 28.94% | -- |
| Average Basic Shares Outstanding | 1,578.68% | 1,552.36% | 1,051.67% | 541.04% | -- |
| Average Diluted Shares Outstanding | 1,578.68% | 1,552.36% | 1,051.67% | 541.04% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |